Prospects for a genomic approach to the treatment of alcoholism.
O'Brien
Charles P
CP
Department of Psychiatry, University of Pennsylvania, Philadelphia VA Medical Center/Mental Illness Research Education and Clinical Center, 3900 Chestnut St, Philadelphia, PA 19104-6178, USA. obrien@mail.trc.upenn.edu
D000437:Alcoholism / Q000235:genetics* / Q000503:physiopathology / Q000534:rehabilitation*; D000483:Alleles; D000818:Animals; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D005819:Genetic Markers / Q000235:genetics*; D023281:Genomics; D006801:Humans; D008253:Macaca mulatta; D009271:Naltrexone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D018847:Opioid Peptides / Q000502:physiology; D017450:Receptors, Opioid, mu / Q000187:drug effects / Q000235:genetics*
D005819:Genetic Markers; D009292:Narcotic Antagonists; C485764:OPRM1 protein, human; D018847:Opioid Peptides; D017450:Receptors, Opioid, mu; D009271:Naltrexone